Five-Year Outcome of MiniArc Single-Incision Sling Used in the Treatment of Primary Urodynamic Stress Incontinence

Abstract

MiniArc maintains its effectiveness and safety in treatment of USI through 5 years with high objective and subjective cure rates and low incidence of complications.

Randomized controlled trial comparing single‐incision mini‐sling and transobturator midurethral sling for the treatment of stress urinary incontinence: 3‐year follow‐up results

“…Similar to our study, other trials reported that questionnaire scores slightly get worse in the medium-term following the expected and natural decline in the efficacy of reconstructive pelvic floor surgeries observed throughout the time. 26,30 In relation to complications, the rates of tape exposure (4.9% in each group) and lower urinary tract symptoms including de novo urgency (12.2% in SIMS and 4.9% in TOT groups) were in accordance to the other reports. [31][32][33][34] A nonsignificant trend towards higher rates of repeat continence surgery was noted in the SIMS group compared to TOT (10.1% and 3.3%, respectively).…”

“…Few studies have reported medium-term outcomes of SIMS. [25][26][27] Overall, the various analyses of our trial demonstrated that objective cure of SUI favored TOT over a SIMS technique in the medium-term. Considering only the participants who completed 3-year follow-up which would best reproduce the treatment differences, cure reached 90.2% for TOT confirming the high success rate for MUS described by literature [21][22][23][24] while SIMS reached 68.3%.…”

“…We observed lower objective cure rates for both procedures with ITT when compared to other reports in literature. 26,27 A retrospective observational study of MiniArc® (American Medical Systems, Minnetonka, MN) showed a decline in the trend of objective cure over time (91.7% at 1-year and 84.7% at 5-year). 26 Sivaslioglu et al 27 reported that the mini-sling Tissue Fixation System® (TFS PTY Ltd, Sydney, Australia) was superior to TOT (83% vs 75% at 5-year follow-up, P 0.029).…”

“…26,27 A retrospective observational study of MiniArc® (American Medical Systems, Minnetonka, MN) showed a decline in the trend of objective cure over time (91.7% at 1-year and 84.7% at 5-year). 26 Sivaslioglu et al 27 reported that the mini-sling Tissue Fixation System® (TFS PTY Ltd, Sydney, Australia) was superior to TOT (83% vs 75% at 5-year follow-up, P 0.029). The inclusion of a wide selection of participants involving complex cases of intrinsic sphincter deficiency and previous anti-incontinence surgery in our study, while most of the trials tend to exclude those cases, may have accounted for our lower rates of cure.…”

“…The use of SIMS is still controversy with the clear need for additional studies that elucidate their role in SUI management. Few studies have reported medium‐term outcomes of SIMS …”